Real-World Evidence (RWE) in Coverage Decisions: European Frameworks for RWE Integration in Pharmaceutical and Device Coverage and Implications for Indian Policy Benefit Design
European Landscape: RWE in Coverage and Reimbursement Frameworks for RWE Integration in Pharmaceuticals Frameworks for RWE Integration in Medical Devices Methodological Considerations in RWE Utilization Implications for Indian Policy Benefit Design Challenges and Opportunities for RWE in India European Landscape: RWE in Coverage and Reimbursement The integration of Real-World Evidence (RWE) into coverage and reimbursement decisions within European healthcare systems represents a significant evolution from traditional evidence generation models, primarily reliant on randomized controlled trials (RCTs). Payers and Health Technology Assessment (HTA) bodies are increasingly recognizing the value of RWE in understanding a product's performance, safety, and effectiveness in routine clinical practice across diverse patient populations and settings. This shift is driven by the need to assess long-term outcomes, cost-effectiveness over the product lifecy...